MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$363,725K
Cash and cash
equivalents
$98,896K
Prepaid expenses and
other current assets
$12,257K
Total current assets
$474,878K
Other long-term
assets
$656K
Operating lease
right-of-use assets
$383K
Deferred offering costs
$217K
Property and equipment,
net
$34K
Total assets
$476,168K
Total liabilities and
stockholders' equity
$476,168K
Total stockholders'
equity
$459,600K
Total liabilities
$16,568K
Accumulated deficit
-$347,166K
Additional paid-in capital
$806,373K
Total current
liabilities
$16,568K
Accumulated other
comprehensive income
$334K
Common stock, par value
0.001 authorized...
$59K
Accrued expenses and
other current...
$14,409K
Accounts payable
$2,159K
Back
Back
Balance Sheet
source: myfinsight.com
Enliven Therapeutics, Inc. (ELVN)
Enliven Therapeutics, Inc. (ELVN)